News and Announcements
FarmaTrust Partners with Gaco Pharmaceuticals to Modernise & Secure it’s Supply Chain
- Published May 11, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- FarmaTrust, a UK-based blockchain venture and international drug tracking system, has announced it’s second partnership in a short span of time with Gaco pharmaceuticals in Bangladesh after its association with Mongolian government.
- The company aims at safe, encrypted, transparent and unquestionable supply chain with elimination of counterfeit drugs.
Farma Trust is a premiere company for blockchain technology innovation which has a holistic approach to do away with fake and imitation drugs and at the same time creating efficiencies for the manufacturers. It intends to provide data analytics, machine learning and automated regulatory repotting which will automatically increase production efficiency and therefore ensure growth of the company.
Omer Farooque, the managing director of Gaco Pharmaceuticals proudly announced about its
association with the company, expecting modernisation and security of their supply chain. He confirmed about availability of an easy access tool, a freely downloadable mobile app to consumers so that they can in turn control the authencity of the medical products they yearn to purchase. Partnership with Farma Trust will provide them cost-efficient and comprehensive information modules. This would help Gaco to retain its credibility, quality of medicines and recognition.
About FarmaTrust
FarmaTrust provides cost effective data services to pharmaceutical companies to meet their compliance requirements, governments, regulators, NGOs and law enforcement. It also gives confidence to consumers (through the free FarmaTrust app) that medicines they purchase are genuine.
Company Updates
Stop Leaving Millions on the Table: The Investor Secret You’re Missing!
In an Australian business landscape increasingly defined by volatility and intense competition for capital, the art of robust stakeholder relations has evolved beyond a mere governance checkbox. For founders, boards, and executive teams, the ability to genuinely inform and engage investors isn’t just about meeting disclosure requirements; it’s a strategic imperative that directly impacts capital […]
Ecosystems Over Exit: Callum Laing on Disrupting Small Business M&A
At Emergence Singapore, Callum Laing of Veblen Director Program presented a bold new vision for small business M&A: “Ecosystems Over Exit.” He shared how his Unity Group takes cash-generating businesses public, focusing on growth over immediate founder exit. Discover his unique approach, how interconnected ecosystems drive massive deal flow, and a three-step framework for any business to amplify reach and capital raising.
Report on the Impact of the Proposed Unrealised Capital Gains Tax on Investment in Key Sectors
A recent survey of investors and company leaders reveals significant concerns about the proposed Unrealised Capital Gains Tax (UCGT) in Australia. Over 84% indicate it would negatively impact investment in vital renewable energy, sustainability, and life science sectors, with 82% believing it would discourage long-term holdings. The report highlights the critical role of SMSF investors in early-stage funding and urges policymakers to reconsider the tax’s potential to stifle innovation and economic growth.
Backed By Leading Investment Groups and Family Offices
